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Background: Traditional teaching assumes that the distal arterial tree is maximally dilated in patients with critical limb
ischemia (CLI). Endovascular or arterial bypass procedures are the commonly used interventions to increase distal
perfusion. However, other forms of treatment such as spinal cord stimulation or intermittent pneumatic compression
(IPC) have been shown to improve limb salvage rates. This prospective study was designed to determine if the use of IPC
increases popliteal, gastrocnemial, collateral arterial, and skin blood flow in patients with CLI.
Methods:Twenty limbs with CLI in 20 patients (mean age, 74 years) were evaluated with duplex ultrasound scans and laser
Doppler fluxmetry in the semi-erect position before, during, and after IPC. One pneumatic cuff was applied on the foot
and the other on the calf. The maximum inflation pressure was 120 mmHg and was applied for 3 seconds at three cycles
per minute. All patients had at least two-level disease by arteriography. Fourteen limbs were characterized as inoperable,
and six were considered marginal for reconstruction. Flow volumes were measured in the popliteal, medial gastrocnemial,
and a genicular collateral artery. Skin blood flux was measured on the dorsum of the foot at the same time.
Results: Significant flow increase during the application of IPC was found in all three arteries (18/20 limbs) compared
with baseline values (P < .02). The highest change was seen in the popliteal, followed by the gastrocnemial and the
collateral artery. After the cessation of IPC, the flow returned to baseline. This was attributed to the elevation of time
average velocity, as the diameter of the arteries remained unchanged. The skin blood flux increased significantly as well (P
< .03). In the two limbs without an increase in the arterial or skin blood flow, significant popliteal vein reflux was found.
Both limbs were amputated shortly after.
Conclusions: IPC increases axial, muscular, collateral, and skin blood flow in patients with CLI and may be beneficial to
those who are not candidates for revascularization. Patients with significant venous reflux may not benefit from IPC. This
supports the theory that one of the mechanisms by which IPC enhances flow is by increasing the arteriovenous pressure
gradient. ( J Vasc Surg 2005;42:710-6.)Intermittent pneumatic compression (IPC) is widely
used as prophylaxis for deep venous thrombosis (DVT).1 In
the early 1930s, IPC was shown to have a positive effect on
lower-extremity blood flow of the calf and foot.2,3 Later,
clinical benefits in patients with various degrees of limb
ischemia were demonstrated, including those with critical
limb ischemia (CLI).4,5
CLI occurs when the blood supply to the capillary beds
is less than that necessary to maintain tissue viability. Arte-
riolar vasodilation, resulting in a reduction of peripheral
vascular resistance, is a compensatory response to CLI.6
Peripheral arterioles in CLI are relatively insensitive to
vasodilator stimuli compared with those in control subjects.
Consequently, arterioles in CLI patients are thought to be
“maximally dilated,” a phenomenon known as vasomotor
paralysis, which has become a traditional assumption.7-9
Significant evidence suggests that IPC increases tempo-
rarily the arterial blood flow in healthy subjects, in patients
with intermittent claudication, and in those with peripheral
arterial disease with prior successful surgical revasculariza-
tion.3,10-14 However, Duplex ultrasound (DU) or laser
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710Doppler blood flow (LDF) evaluation of the lower extrem-
ities in patients with CLI has not been yet reported. We
postulate that the demonstrated clinical effect of IPC on
limbs with CLI is due to further increases in the arterial
blood flow at all levels, either because of a reversal of
vasomotor paralysis or an increase in the lower-extremity
arteriovenous gradient caused by venous emptying from
intermittent compression.
This prospective study was designed to measure the
hemodynamic effects of IPC in patients with CLI in the
systemic, muscular, and collateral circulation as well as in
the foot skin blood flow.
PATIENTS AND METHODS
Limbs of patients with CLI were evaluated with DU
and LDF in the semi-erect position before, during, and
after IPC. CLI was defined according to the TransAtlantic
Inter-Society Consensus document15 as those patients
whose arterial disease has resulted in a breakdown of the
skin (ulcer or gangrene) or pain in the foot at rest. It
corresponds to stages III and IV of the Fontaine classifica-
tion. The semi-erect position was chosen to study these
limbs for two reasons: it was the natural position adopted
by these patients because of severe discomfort while lying
supine, and to increase the arterio-venous gradient.16-18
The ArtAssist device (model AA-1000; ACI Medical
Inc., San Marcos, California) was used in all cases. Inflat-
able 12- and 22-cm bladders in a single cuff structure were
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inflation pressure of 120 mmHg was applied for 3 seconds
at three cycles per minute. The foot bladder was inflated
first, and the calf bladder, 2 seconds later. This is a rapid
inflation device, with a time of 300 to 360 milliseconds to
reach peak pressure.
All patients underwent digital subtraction arteriogra-
phy to optimize visualization and vessel conspicuity with
maximum contrast of the potential distal target arteries.
The images were obtained with the target limb gently but
securely immobilized to limit patient motion, which would
cause misregistration artifact on the digital subtraction
images. Whenever possible, the target area was imaged in
an anatomic position (either anteroposterior or lateral) to
optimize correct identification of distal target vessels.
Nonionic and isosmolar contrast agents were used to
minimize patient discomfort. Appropriate collimation, fil-
tering and catheter positioning were used to optimize
radiographic exposure in the target area. Whenever possi-
ble, contrast was injected from the ipsilateral side to maxi-
mize contrast opacification. Long, 5- to 10-second infusion
times and delay were used to allow for complete filling of
any patent channels in the target extremity. Peripheral
vasodilators (tolazoline, nitroglycerine) or hot compress
warming were often used to maximize peripheral vasodila-
tation.
The images were reviewed by an interventional radiol-
ogist (M. B.) and by two vascular surgeons (A.M., S. S. K.).
They were classified as inoperable if no target vessels were
identified for revascularization and marginal for recon-
struction if the target vessels had a small caliber or diffuse
disease that made them not suitable for a durable bypass
procedure or intervention.
For the purpose of this study, patients selected had a
patent popliteal artery. Before each measurement, the sub-
jects were acclimatized in supine position on a couch for at
least 10 minutes. Flow volumes were measured in the
popliteal, medial gastrocnemius, and a genicular collateral
artery. Artery blood flow was measured by using a 4- to
7-MHz linear array transducer (ATL-Ultramark 9; Ad-
vanced Tech Laboratory, Bothell, Wash). The internal ar-
terial diameter was measured by imaging the vessel longi-
tudinally with real time B-mode. The average of three
repeated measurements was obtained. Velocity measure-
ments were performed at an angle of 60°, with the gate of
the sample volume matching the internal diameter of the
artery. The mean volume flow was calculated from the time
average mean velocity of at least five cycles.
At the same time, skin blood flux was measured at the
dorsum of the foot by using LDF (Laserflo model BPM
403A, TSI Inc, St Paul, Minn) and recorded in flux units.
The BPM 403A has a semiconductor gallium-aluminum-
arsenide diode that emits a laser beam with a 780-nm
wavelength. For all studies, a right angle probe was used.
The probe was fixed on the skin by means of a double
adhesive ring and adhesive tape. LDF readings at rest,
before the initiation of the pump, were stabilized over a
5-minute period. The average resting skin blood flow wascalculated over 30 seconds. The skin blood flow during the
pump application was not measured because of significant
motion artifact and was averaged for 10 seconds immedi-
ately after.
No attempts were made to correlate the hemodynamic
findings with transcutaneous oxygen pressure measure-
ments (TcPO2), as they were not performed simultaneously
with the other two methods.
The degree of discomfort produced by the application
of the pump was graded as none, mild, moderate, and
severe. In cases of severe discomfort, the pump was discon-
tinued and the patient was excluded from the study.
Statistical analysis. Descriptive statistics were used
for patient demographic characteristics. A paired t test was
used to compare the arterial flows and diameters before,
during, and after the application of IPC. Data were ex-
pressed as a mean and 95% confidence intervals (CI). The
Wilcoxon sum-rank test was used for the LDF data, as their
distribution was nonparametric. These data were expressed
as median and interquartile range (IQR). The level for
statistical significance was set at P  .05.
RESULTS
Twenty limbs with CLI in 20 patients (mean age, 74
years) were evaluated. The demographic characteristics are
summarized in Table I. An additional patient was excluded
because of inability to tolerate the foot component of the
pump due to severe pain. All other patients tolerated it well,
with mild-to-moderate discomfort that disappeared after a
few pump cycles. All of the patients in our study had rest
pain, and nine had tissue loss. All had an ankle-brachial
index (ABI) of 0.3, and the mean TcPO2 was 21.6. All
patients had at least two-level disease by arteriography.
Stenosis or occlusion in the aortoiliac segment was found in
17 patients, common femoral in 6, deep femoral in 6,
superficial femoral in 18, and all patients had infrapopliteal
disease. Fourteen limbs were inoperable, and six were mar-
ginal for reconstruction.
Significant flow increase during the application of IPC
Table I. Demographic characteristics of the study
population before intervention
Mean age (range) 74 (65–83)
Males 13
Females 7
Mean ABI (range) 0.25 (0.1–0.29)
Mean TcPO2 (range) 21.6 (12–31)
Diabetes mellitus 10
Hypertension 15
Hypercholesterolemia 13
Smoking 12
Coronary artery disease 11
Rest pain 20
Tissue loss 9
History of stroke 2
History of prior bypass 8
ABI, Ankle-brachial index; TcPO2, transcutaneous oxygen pressure measure-
ments.was found in all three arteries (18/20 limbs) compared
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change was seen in the popliteal (104.5%), followed by the
gastrocnemial (70%) and the collateral artery (55.6%). After
the cessation of IPC, the flow returned to baseline. This was
attributed to the elevation of time average velocity as the
diameter of the arteries remained unchanged (Fig 1 and
Table III). The skin blood flux increased significantly as
well (3.5 flux units, IQR 2 to 4.2 vs 5.2 flux units, IQR 3.8
to 6.2; P  .03) (Fig 2).
In the two limbs without an increase in the arterial or
skin blood flow, significant popliteal vein reflux was found
(Fig 3). This reflux was of high velocity and 5 seconds in
duration in both cases. Both limbs were amputated shortly
after. The remaining 18 patients did not have popliteal
reflux. The rest of the veins were not examined, but none of
them had clinically evident varicose veins or a history of
venous thrombosis. Two patients were lost at a 6-month
follow-up. Four patients underwent amputations at 10, 14,
30, and 60 days after the experiment.
DISCUSSION
Several trials on the effects of IPC on the arterial system
in the lower limbs have been reported. A meta-analysis of
studies between 1966 and 2001 identified several limita-
tions.19 There were differences in the type of devices used
(sequential vs simultaneous compression), protocols of cy-
cle length, and duration of treatment, severity of limb
ischemia, flowmeasurement techniques, and end points for
analysis. Moreover, only three prospective randomized
studies were found, all with small sample sizes. Despite
those limitations, a clear trend toward a favorable effect on
limb hemodynamics was observed.
The first prospective, randomized, controlled evidence
for an increase in arterial blood flow with IPC in patients
with intermittent claudication was reported in 1993,20 and
that was followed by three additional trials.5,21,22 They
showed significant beneficial effects on walking distance,
symptoms, and systolic blood pressure measurements on
the upper and lower limbs with therapy. However, studies
on CLI and IPC have been limited to clinical out-
comes4,23-25 and case reports.26 The case series are mostly
Table II. Mean and 95% confidence intervals (CI) of
arterial blood flow before, during, and after intermittent
pneumatic compression
Artery Mean 95% CI
Popliteal Before 22 19.7–24.3
During 45 39.4–50.6
After 20 17.7–22.3
Gastrocnemial Before 10 8.6–11.4
During 17 15.1–18.9
After 9 7.6–10.4
Collateral Before 9 8.06–9.94
During 14 12.6–15.4
After 8 6.6–9.4
P  .01 for comparisons before vs during, and during vs after, in all three
arteries. The before and after values were comparable.retrospective.23,24Montori et al23 retrospectively analyzed IPC in 107
patients with arterial ulcers. With a median follow-up of 6
months, wound healing was seen in 40% of patients with
TcPO2 levels 20 mm Hg. Vella et al
24 retrospectively
analyzed IPC in 96 patients with ischemic ulcers and found
benefit in their treatment at all TcPO2 levels. Van Bem-
melen et al25 studied 14 consecutive ischemic legs in a
Veterans Administration hospital. The patients were
deemed poor candidates for surgery and were treated with
IPC for 4 hours per day at home for 3 months. Clinical
outcomes and calibrated pulse-volume amplitudes were
recorded. Nine legs were salvaged.
The only prospective trial was a pilot study of clinical
outcomes involving IPC therapy of 33 limbs with CLI.4 At
a mean follow-up of 3 months, 58% of legs were saved. Rest
pain improved in 40% of patients, 26% of foot ulcers healed,
and toe pressures significantly improved.
Several studies have shown increased popliteal artery
blood flow during IPC application in healthy subjects and
Fig 1. Color flow duplex imaging in the evaluation of volume
blood flow in the popliteal artery. A, At rest, the waveform is
abnormal because of multiple levels of disease. B, during intermit-
tent pneumatic compression application, the volume flow almost
doubled, with significant increase in both the peak systolic and
end-diastolic velocities.in patients with claudication.13,14,32,34 However, our study
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popliteal artery blood flow in patients with CLI. It is also
the first study to demonstrate significant flow increases in
muscular and collateral arteries. The previous reports and
the current study support arteriovenous pressure gradient
augmentation as the main mechanism for the flow increase.
This has been shown by the reduction of the venous pres-
sure during IPC application.16 In the sitting position, the
venous pressure in the foot is about 60 mm Hg. The
application of IPC reduces this pressure and therefore
increases the arteriovenous pressure gradient.
The resting blood flow in the popliteal artery in patients
with CLI is reported for the first time in the literature.
Compared with previous publications, the resting blood
flow in the sitting position in claudicants is significantly
higher than in our patients with CLI.13,34 This can be
explained by the multiple levels of the occlusive disease as
depicted by the angiograms and the very low ABI values.
The relative increase of blood flow volumes in patients with
CLI was significant for all three arteries during IPC. How-
ever, the magnitude of change was significantly less com-
pared with previous studies that evaluated patients with
claudication.13,34 With increasing levels of disease, more
vasodilatation is likely present, and therefore, the margin
for flow enhancement is less.
Vasodilatation is one of themechanisms by which limbs
with non-CLI obtain an increase in their blood flow.27 This
is through the production of nitric oxide duringmechanical
stimulation (device inflation). It has been recently pro-
posed that the application of IPC causes a forward pulsatile
flow, resulting in emptying of blood at that site. The
increase of blood volume and velocity exerts a compressive
strain and enhances the shear stress on the venous endothe-
lial cells.27 IPC has also an effect on the arterial system, as
Table III. Mean vessel diameters (95% confidence interva
pneumatic compression
Artery Before
Popliteal 4.02 (3.69–4.31; 3–5.7)
Gastrocnemial 1.91 (1.72–2.08; 1.3–2.9)
Collateral 1.79 (1.60–1.98; 1.1–2.8)
P  .1 for comparisons before, during, and after in all three arteries
Fig 2. Laser Doppler flux recording at rest, during, and after the
application of intermittent pneumatic compression. During inter-
mittent pneumatic compression, there is a motion artifact with a
gradual increase of the flux.the sudden drop in the venous pressure causes an increase inthe arteriovenous gradient that augments the arterial blood
velocity. As a consequence, the shear stress on arterial
endothelial cells is increased.27 Cell cultures and animal
models have shown that the mechanical forces of shear and
strain may elicit vasodilatory, antithrombotic, and profi-
brinolytic responses in endothelial cells.27
Patients with CLI are assumed to have maximal vessel
dilatation caused by the critical lack of oxygen.7-9 Our
findings bring the possibility of a submaximal level of
dilatation, which could be raised with compression. Such
vasodilation should occur in the arteriolar level, as we
showed that there is no change in the diameter of the
popliteal, gastrocnemial, and collateral arteries during IPC.
Other studies have also shown no change in the diameter of
the popliteal artery in healthy subjects and in patients with
claudication during IPC.22,32,33 This is also substantiated
by the increased LDF in our patients, which measures flow
in the microcirculation. Further research is required to
elucidate this matter.
Another question is related to the magnitude of the
blood flow increase. We hypothesize that collaterals
showed the lowest increase in blood flow because vessel
dilatation in these arteries is likely almost maximum. The
same theory may be applicable to muscular arteries, smaller
in size and probably fully dilated because of muscle isch-
emia. The popliteal artery had the greatest flow increase.
This was possibly because of the additive effect of the
diminished peripheral resistance in collateral and muscular
branches that the main popliteal artery supplies.
It is of interest to observe two occurrences of popliteal
vein reflux in patients who ultimately underwent limb
amputation shortly after the study. No reports have ad-
dressed the causes for failure to achieve beneficial arterial
hemodynamic effects with IPC. Malone et al28 demon-
strated that patients with post-thrombotic venous disease
have a compromised venous hemodynamic response to all
IPC devices. Furthermore, they showed an increased veloc-
ity response to high-pressure, rapid-inflation IPC ma-
chines. But this has only been evaluated in the context of
DVT prophylaxis. Van Bemmelen et al25 did not see any
hemodynamic improvement in limbs that were amputated
after IPC therapy. No comments are made as to the reasons
for failure and no documentation of reflux made.
Conceivably, significant axial vein reflux will impede a
clinically significant arteriovenous gradient, limiting flow
augmentation in the arterial system, supporting further this
theory as the underlying mechanism for the success of IPC
ge) in millimeters, before, during, and after intermittent
ring After
6 (3.77–4.35; 3.2–5.7) 3.94 (3.65–4.21; 3–5.5)
5 (1.75–2.14; 1.3–3) 1.86 (1.66–2.04; 1.2–3)
2 (1.63–2.01; 1.1–2.8) 1.75 (1.56–1.94; 1.1–2.6)l; ran
Du
4.0
1.9
1.8devices. The introduction of novel IPC designs could po-
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subjects.29 Commercially available IPC devices have con-
stant cycles of compression and deflation. It has been
shown that vein refilling times vary with limb position and
with different venous pathologies.29,30 Relatively new sys-
tems have been designed with the ability to detect venous
Fig 3. Popliteal artery blood flow in a patient with significant
popliteal reflux after a femoropopliteal thrombosis. A, Flow at rest
has high resistance due to popliteal vein insufficiency. B, High
velocity and long duration of reflux in popliteal vein.C, No change
in the volume flow is seen during the application of intermittent
pneumatic compression.volume changes and to respond by initiating the subse-quent cycle when the veins are again full. So far, this
technology has not been tested from the arterial flow point
of view but appears feasible and promising.
No studies have been designed to identify the ideal
compression sequence to enhance arterial blood flow max-
imally in the lower limbs of patients with ischemia. How-
ever, following the premise that IPC acts through enhance-
ment of venous flow and increasing the arteriovenous
gradient, we chose our treatment strategy by selecting the
optimal way for venous emptying. This was based on a
study that showed that foot and calf compression of 120 to
140 mmHgwith a frequency of 3 to 4 impulses per minute
and 1-second delay was the optimum stimulus, as it had the
maximal reduction in the venous pressure.16
LDF has been used to assess blood flow at the foot skin
level in patients with different levels of limb ischemia.12,35
However, foot skin level assessment of blood flow has never
been reported in patients with CLI. Our study is the first
evidence of an improvement of blood flow at the skin level
in this subgroup, which once more is against the presumed
clinical dictum of maximal dilatation. This supports further
the theory of a submaximal level of dilatation even at the
skin capillary level, which is ultimately required for the
healing of ulcers caused by arterial disease.
Nailfold capillary video microscopy has shown that the
arteriolar postural vasoconstriction is abolished in patients
with CLI.36 It has also demonstrated that the capillary
density increases significantly from the supine to the depen-
dent position. These phenomena explain why patients with
CLI prefer to have their limbs in the dependent position.
As previously mentioned, the application of IPC is
effective in reducing the venous pressure, further increasing
the limb blood flow. The increase in LDF at the foot
supports these findings and implies significant changes at
the arteriolar level. The marked increase of blood flow at
the systemic, muscular, collateral, and skin levels provide
useful evidence for the application of IPC in this cohort of
patients when no other options for limb salvage are avail-
able.
Only one patient in our series had severe pain due to
IPC application. Seven of 107 patients in the Montori et al
series23 discontinued the device because of pain experi-
enced with its use. These results suggest that this machine is
well tolerated by most patients. Clinically, these devices can
still be used on those few patients that experience pain by
omitting the bladder that compresses the sensitive area.
Later, the bladder may be reintroduced into therapy if
tolerated.
Limitations. We did not analyze the effect of patient
position during the test to see how much of the improve-
ment was due to arteriovenous gradient vs vasodilatation.
All of our patients were tested in the semi-erect position
because they tolerated the application of IPC better and
because it has been proven to be optimal for venous emp-
tying and arterial flow enhancement.13,16
Volume flow measurements were performed by using
the internal diameter of the arteries, assuming that these
vessels were perfect cylinders. However, they were often
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measurement. Since the location of the measurement was
kept constant and each vessel as its own control, this should
not have a significant effect in the results of the study.
No correlation was made with TcPO2 measurements.
Even though all of our patients had this test performed,
they were not simultaneously done with DU or LDF.
These, added to the inherent variability and limited reliabil-
ity of this exam, were reasons not to include TcPO2 results
in the final analysis.
It is important to mention that all 20 patients had a
patent popliteal artery; therefore, our findings apply only to
CLI patients with such an anatomic configuration. Patients
with CLI who have this condition may be selectively advan-
taged compared with those with popliteal artery occlusion.
IPC may be beneficial for this subgroup of patients, how-
ever, as the collateral and muscular artery flow were shown
to improve as well.
Finally, no long-term clinical follow-up was available to
address the clinical impact of the hemodynamic changes in
this subset of patients. As this was an acute-phase experi-
ment, no detailed follow-up was available other than the
amputations performed within 6 months. However, several
clinical trials have suggested that this technique is associ-
ated with an improved rate of limb salvage, wound healing,
and improvement in ischemic symptoms.
CONCLUSIONS
This is the first evidence to show IPC improvements at
all levels: axial, muscular, and collateral arteries as well as in
skin blood flow in patients with CLI. This treatment is well
tolerated and may be beneficial to those who are not
candidates for revascularization. Patients with significant
venous reflux may not benefit from IPC. This supports the
theory that IPC enhances flow by increasing the arterio-
venous pressure gradient. Our findings also support the
theory that distal vasodilatation is not maximal in areas of
ischemia and that further decreases in their vascular resis-
tance can be achieved with IPC. As one of the most
skeptical surgeons have acknowledged,31 the time for a
multicenter randomized trial has come.
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